-
What About The Kids? Children's Hospitalizations For Cannabis Poisoning Are On The Rise
Thursday, August 25, 2022 - 9:42am | 777The number of children hospitalized for marijuana poisoning notably rose in several Canadian provinces after they had legalized edibles, reveals a new study published Wednesday in the New England Journal of Medicine. Researchers discovered that Alberta, British Columbia and Ontario...
-
'No Temperature Rise Is Safe': Top Health Experts Warn Climate Change Is Biggest Health Threat
Tuesday, September 7, 2021 - 2:34pm | 675Medical experts are worried. That is, top health officials from the leading medical journals across the world — including Africa, the Americas, Asia and Europe — are calling for action to keep temperature increases below 1.5 degrees Celsius to prevent devastation that will likely be...
-
Analyst On La Jolla's Hypotension Drug: We Expect Approval Next Year
Monday, May 22, 2017 - 11:23am | 611Following the publication of full data from a late-stage study of La Jolla Pharmaceutical Company (NASDAQ: LJPC)'s LPJC-501, a proprietary formulation of angiotensin II, SunTrust Robinson Humphrey said it expects approval in 2018. The Study And The Results The full data from the Phase III study,...
-
La Jolla Meets ATHOS-3 Trial Endpoints, Dispels Market Controversy In The Process
Monday, May 22, 2017 - 9:34am | 366Shares of La Jolla Pharmaceutical Company (NASDAQ: LJPC) were trading lower by more than 8 percent Monday morning after the company released Phase 3 results in the New England Journal of Medicine from a study called ATHOS-3, which evaluated the company's therapy LJPC-501 for the treatment of...
-
ThinkEquity Rates Vertex Pharmaceuticals (VRTX) A Hold
Thursday, April 8, 2010 - 12:12pm | 164ThinkEquity LLC analyst Brian Skorney maintained his Hold rating for shares of Vertex Pharmaceuticals Inc. (Nasdaq: VRTX). Skorney wrote that he maintained his Hold rating for Vertex Pharmaceuticals Inc. because he thought that shares of the biotechnology company were fairly valued. Although...